Common Induction Therapies: How Does the Oncologist or Specialist Decide?
With the amazing research being made in the myeloma field, there are now more front-line therapies than ever. What are your options? How does your doctor determine which induction therapy is right for you? Join Dr. Diamond as he walks us through this complex decision.
Audrey Burton-Bethke
Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Benjamin Diamond, MD
Dr. Diamond is a hematologist/oncologist who specializes in the treatment of plasma cell disorders including monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma. His research interests include utilization of minimal residual disease (MRD)-guided approaches to clinical decision-making, maintenance therapy, and the genomics of multiple myeloma and secondary malignancies that occur in patients treated for multiple myeloma. He completed fellowship at Memorial Sloan Kettering Cancer Center, spending a year as chief fellow, and is a member of the Myeloma Genomics Laboratory at Sylvester Comprehensive Cancer Center.